Credit: Getty Images Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a first-degree relative who has DLB, including a 2-fold ...
Cognition Therapeutics, Inc. (NASDAQ:CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders including dementia with Lewy bodies (DLB), had the opportunity to raise ...
At the International Dementia with Lewy Body Conference, held December 1-4 in Fort Lauderdale, Florida, brain imaging emerged as a promising adjunct to figuring out exactly what is going on in a ...